Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 7 of 7 clinical reviews.
A deep-dive into the enrollment biases, generalizability gaps, statistical caveats, and conflict-of-interest issues in the SURMOUNT-2 trial of tirzepatide for weight loss in type 2 diabetes.
Read clinical reviewA deep-dive into the SURMOUNT-2 trial design, randomization, estimand framework, and statistical choices that shaped tirzepatide's weight-loss results in type 2 diabetes.
Read clinical reviewA detailed look at cost-per-QALY modeling, payer-coverage logic, list vs net price reality, and the individual patient value calculation stemming from the SURMOUNT-2 tirzepatide trial in adults with type 2 diabetes.
Read clinical reviewDeep-dive into SURMOUNT-2 follow-up and extension findings for tirzepatide in type 2 diabetes, covering durability of weight loss, weight regain after discontinuation, and long-term safety signals.
Read clinical reviewA deep-dive into the SURMOUNT-2 trial results for tirzepatide in type 2 diabetes, covering primary and secondary endpoints, effect sizes, confidence intervals, response distributions, and the weekly weight-loss trajectory.
Read clinical reviewDeep-dive into SURMOUNT-2 pre-specified and post-hoc subgroup analyses for tirzepatide in type 2 diabetes: responses by age, sex, BMI, race, and baseline biomarkers.
Read clinical reviewA deep-dive into the SURMOUNT-2 trial of tirzepatide in type 2 diabetes, examining which guidelines shifted, how prescribing patterns changed, and what the results mean for real-world patients.
Read clinical review